Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion type Assertion NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_head.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion description "[The CYP1A1*2C (p = 0.011, OR: 6.62, and 95% CI: 1.56-28.10), GSTT1 null (p < or = 0.001, OR: 11.94, 95% CI: 7.88-18.12), and GSTP1 TT genotypes (p = 0.017, OR: 3.42, 95% CI 1.26-9.38) demonstrated significant association of DLBCL risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_provenance.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion evidence source_evidence_literature NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_provenance.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion SIO_000772 18203021 NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_provenance.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion wasDerivedFrom gad-20150221 NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_provenance.
- NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_assertion wasGeneratedBy ECO_0000203 NP137579.RAoxNWGTZ3Mr9eBOrue5oR9HE0PTBp-4v_xe1p0HA9Nes130_provenance.